Isotretinoin Actavis

Isotretinoin, the active ingredient in Isotretinoin Actavis, is a retinoid presented as oral capsules for oral use. It is indicated for the treatment of severe nodular acne and acne vulgaris that has not responded to conventional therapies, helping to reduce lesions and prevent new breakouts.

GNH USA supplies Isotretinoin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand through reliable logistics and comprehensive documentation.

Isotretinoin is a retinoid used primarily in the management of severe acne conditions.

Severe nodular acne: reduces inflammatory nodules and prevents formation of new lesions. Cystic acne: decreases cystic lesions and improves skin appearance. Acne vulgaris refractory to other treatments: lowers comedone count and controls persistent breakouts.

Isotretinoin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin: increased epidermal dryness and scaling. - Cheilitis: cracked, painful lips. - Xerosis of mucous membranes: dryness of eyes and nasal passages. - Photosensitivity: heightened skin reaction to sunlight. - Elevated liver enzymes: mild transaminase increase. - Hypertriglyceridemia: rise in blood triglyceride levels.

Serious or Rare Side Effects: - Teratogenicity: severe birth defects if exposure occurs during pregnancy. - Pseudotumor cerebri: increased intracranial pressure presenting with headache and visual changes. - Severe depression or suicidal ideation: mood alterations requiring immediate evaluation. - Pancreatitis: acute inflammation of the pancreas associated with high triglycerides.

Before initiating isotretinoin therapy, several precautions should be observed to ensure patient safety.

- Pregnancy testing: confirm negative pregnancy test before start and use effective contraception throughout treatment. - Contraception: two reliable forms of birth control must be maintained during therapy and for one month after discontinuation. - Liver function monitoring: assess baseline hepatic enzymes and repeat periodically during treatment. - Lipid monitoring: check serum triglycerides before therapy and monitor during treatment. - Vitamin A intake: avoid concurrent high‑dose vitamin A supplements to prevent toxicity. - Store at ambient temperature: keep capsules below 25 °C in the original container, protected from moisture and light.

Isotretinoin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Vitamin A supplements: additive retinoid toxicity. - Tetracycline antibiotics (e.g., doxycycline): increased risk of intracranial hypertension. - Systemic retinoids (e.g., acitretin): cumulative teratogenic risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: isotretinoin may reduce contraceptive effectiveness; additional barrier methods recommended. - Anticoagulants (warfarin): possible enhancement of anticoagulant effect, monitor INR. - Corticosteroids: may mask signs of infection; monitor for adverse effects.